Dr. James T. Stenard, MD

Dr. Stenard practices at Nephrology Associates in Augusta, Georgia.

Dr. Stenard's NPI, 1396275491, was assigned on June 13, 2017. Dr. Stenard holds Georgia license 92656.

Dr. Stenard's primary practice is Nephrology Associates, at 701 Greene St, Augusta, GA 30901 in Richmond County. The practice phone is (706) 722-6900.

Dr. Stenard's primary practice is Nephrology Associates in Augusta, Georgia. Dr. Stenard is also affiliated with Piedmont Augusta. The medical group on file is Nephrology Associates, P.C. Dmand AI also links Dr. Stenard to 3 more hospitals, 3 dialysis centers and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Stenard practices, 8 sites in all. Vendor and product names are available with a free account.

Nephrology is Dr. Stenard's primary specialty in the NPI Registry, under taxonomy code 207RN0300X. Dmand AI has Dr. Stenard's licenses on file in 3 states: Georgia, Pennsylvania and South Carolina.

CMS data shows 3,714 Medicare services from Dr. Stenard across 22 procedure codes in 2024, for 492 Medicare patients. Medicare paid $200,958 for them.

CMS counts 492 Medicare patients who saw Dr. Stenard in 2024. The largest group is 75 to 84, with 194 patients. 75% of them have chronic kidney disease, and 75% have high blood pressure. 27% are also on Medicaid. Their average risk score is 4.20, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Stenard's median patient age at 72, with 54% women.

In 2024, Dr. Stenard wrote 1,521 Medicare Part D claims for 314 patients. 54% of them were for generic drugs. CMS names the drug for 1,375 of them, across 32 drugs with 11 or more claims each, at $667,531 in total drug cost. In 2023, CMS named 661 claims across 19 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for Dr. Stenard for performance year 2024, reported individually. Dr. Stenard accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 139 general payments to Dr. Stenard from 19 drug and device companies from 2022 to 2025. Food and beverage make up the largest share, 95% of the total. Bayer HealthCare Pharmaceuticals Inc. paid the most, $608.